Guardant Health Inc
NASDAQ:GH

Watchlist Manager
Guardant Health Inc Logo
Guardant Health Inc
NASDAQ:GH
Watchlist
Price: 103.21 USD -0.92% Market Closed
Market Cap: 13.3B USD

During the last 3 months Guardant Health Inc insiders have not bought any shares, and sold 4.8m USD worth of shares. The stock price has increased by 82% over this period (open performance analysis).

The last transaction was made on Dec 5, 2025 by Clark Ian T (Chief Technical Officer) , who sold 870k USD worth of GH shares.

Last Transactions:
Clark Ian T
Chief Technical Officer
$-870k
Bell Michael Brian
Chief Financial Officer
$-814.7k
Freeman Chris
Chief Financial Officer
$-48.5k
Monroe Terilyn J.
$-2m
Tariq Musa
$-11.2k
Saia John G.
$-865.9k
Hidalgo Medina Manuel
$-95.2k
Tariq Musa
$-7.8k
Potter Myrtle S
$-1.7k
Potter Myrtle S
$-1.4k
Tariq Musa
$-6.5k
Hidalgo Medina Manuel
$-117.3k
Eltoukhy Helmy
$-17.5m
Joyce Meghan V.
$-6.6k
Kalia Kumud
$-123.5k
Tariq Musa
$-6.8k
Potter Myrtle S
$-1.5k
Potter Myrtle S
$-1.3k
Tariq Musa
$-5.6k
Talasaz Amirali
$-3.7m
Potter Myrtle S
$-1.3k
Tariq Musa
$-158.9k
Clark Ian T
$-322.8k
Potter Myrtle S
$-130.5k
Joyce Meghan V.
$-157.6k
Talasaz Amirali
$-3.9m
Talasaz Amirali
$-2m
Talasaz Amirali
$-84k
Kalia Kumud
$-185.6k
Joyce Meghan V.
$-4.2k
Tariq Musa
$-4.6k
Talasaz Amirali
$-703.2k
View All Transactions

During the last 3 months Guardant Health Inc insiders have not bought any shares, and sold 4.8m USD worth of shares. The stock price has increased by 82% over this period (open performance analysis).

The last transaction was made on Dec 5, 2025 by Clark Ian T (Chief Technical Officer) , who sold 870k USD worth of GH shares.

Sold
0-3
months
4.8m USD
8
3-6
months
22.1m USD
7
6-9
months
7.9m USD
4
9-12
months
99.5k USD
2
Bought
0-3
months
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
0
0 USD

Guardant Health Inc
Insider Trading Chart

Guardant Health Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Guardant Health Inc
Last Insider Transactions

Global
Insiders Monitor

Guardant Health Inc
Glance View

Market Cap
12.9B USD
Industry
Health Care

Guardant Health Inc. emerged from the convergence of innovation and necessity, pioneering a transformative approach to cancer diagnostics. Founded in 2012 by Helmy Eltoukhy and AmirAli Talasaz, the company focuses on the potential of liquid biopsy technology. Unlike traditional biopsies that often require invasive procedures, Guardant Health's tests analyze circulating tumor DNA (ctDNA) from a simple blood draw. This standout technology not only provides critical insights into the genomic profile of tumors but also facilitates early cancer detection, treatment monitoring, and recurrence detection, breaking new grounds in precision oncology. The company's flagship product, Guardant360, plays a pivotal role for oncologists by enabling tailored treatment plans based on real-time, dynamic insights into the cancer's genetic mutations. Earning its revenue primarily through partnerships with healthcare providers, pharmaceutical companies, and research institutions, Guardant Health has positioned itself strategically in the medical diagnostics landscape. By offering tests that can be repeatedly adapted to monitor the evolution of cancer over time, the company garners significant interest as it aids in the development of targeted cancer therapies. Pharmaceutical companies, in particular, collaborate with Guardant Health to utilize its technology in clinical trials to identify suitable candidates and assess treatment efficacy. The company's growing influence is further bolstered by its commitment to expanding applications for early cancer detection, laying the groundwork for potential shifts in cancer care paradigms. Thus, Guardant Health, through its innovative fusions of technology and healthcare, forges ahead in transforming cancer management and diagnostics, turning its story into a testament of modern medical advancement.

GH Intrinsic Value
50.09 USD
Overvaluation 51%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top